Literature DB >> 23739546

Under-utilization of donor hearts in the initial era of the heart transplant program in Korea- review of 13 years’ experience from the Korea national registry.

Myung-Jin Cha1, Hae-Young Lee, Hyun-Jai Cho, Ho Young Hwang, Ki-Bong Kim, Byung-Hee Oh.   

Abstract

BACKGROUND: Heart transplantation (HTPL) is the effective treatment option to improve quality of life as well as survival of terminal heart failure patients. Shortage of donors, however, limits HTPL to all indicated cases. The temporal trend and clinical characteristics of HTPL donors in Korea were therefore investigated. METHODS AND
RESULTS: Among 2,001 brain-death donors registered in Korean Network for Organ Sharing from February 2000 to May 2012, a total of 28% of hearts (n=552) were utilized for HTPL. The mean age of Korean heart donors was 10 years younger than that of heart recipients (33.2 ± 12 years vs. 43.2 ± 17 years, respectively). The oldest was 56 years old, and donors aged over 50 accounted for only 6.2% (n=34) of total cases. Female donors were utilized less than male donors (23.6% vs. 29.6%, respectively). To determine characteristics of declined donor heart candidates, subgroup analysis of echocardiographic data was done, and 74.6% had normal ventricular function and structure, although only 42.3% were actually transplanted. The utilization rate of donor hearts with minor echocardiography abnormalities was only 15.2%. Clinical outcomes of marginal heart donors were not different from non-marginal donors.
CONCLUSIONS: Although shortage of donor organs is an emerging issue, most donor hearts have been under-utilized in the past in Korea. In particular, aged and female donor hearts with minor echocardiographic abnormalities had a low rate of utilization.

Entities:  

Mesh:

Year:  2013        PMID: 23739546     DOI: 10.1253/circj.cj-12-1269

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  4 in total

1.  Similar survival in patients following heart transplantation receiving induction therapy using daclizumab vs. basiliximab.

Authors:  Spencer T Martin; Tomoko S Kato; Maryjane Farr; Jaclyn T McKeen; Faisal Cheema; Mengxi Ji; Alexandra Ross; Halit Yerebakan; Yoshifumi Naka; Hiroo Takayama; Susan Restaino; Donna Mancini; P Christian Schulze
Journal:  Circ J       Date:  2014-12-12       Impact factor: 2.993

2.  Donor Heart Utilization in Korea.

Authors:  In-Cheol Kim; Jong-Chan Youn; Sang Eun Lee; Sung-Ho Jung; Jae-Joong Kim
Journal:  Int J Heart Fail       Date:  2020-05-07

Review 3.  Pediatric heart failure: current state and future possibilities.

Authors:  Joseph W Rossano; Gi Young Jang
Journal:  Korean Circ J       Date:  2015-01-26       Impact factor: 3.243

4.  Initial Report of the Korean Organ Transplant Registry (KOTRY): Heart Transplantation.

Authors:  Hae Young Lee; Eun Seok Jeon; Seok Min Kang; Jae Joong Kim
Journal:  Korean Circ J       Date:  2017-08-16       Impact factor: 3.243

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.